testicular cancer
-
What is testicular cancer?
Testicular cancer is a disease marked by the uncontrolled growth of cells in the testis, the reproductive organ that produces sperm. It is the most common malignancy in men between the ages of 15 and 35, representing 1% of all cancers in males.
Most testicular cancers (90-95%) are germ cell tumors, classified as seminomas or nonseminomas. Cryptorchidism, where one or both testes fail to descend into the scrotum, is a notable risk factor. Testicular cancer typically manifests as a painless lump in either testis, which can be associated with swelling or pain in the scrotum or a dull ache in the lower abdomen.
2 Britannica SourcesCreated from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles. -
Where does testicular cancer develop in the body?
Testicular cancer develops within the testis, the male reproductive organ responsible for sperm production. It occurs when cells within the testis grow uncontrollably. Most testicular cancers (90-95%) are germ cell tumors, which originate from sperm precursor cells. These are classified as either seminomas, which are derived from immature germ cells in the seminiferous tubules, or nonseminomas, which are derived from mature germ cells. Testicular tumors are usually malignant, with the most common symptom being painless enlargement of the testis.
2 Britannica SourcesCreated from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles. -
What are common symptoms of testicular cancer?
Testicular cancer often presents without identifiable risk factors, though cryptorchidism is a notable risk factor. It generally manifests as a painless lump in one of the testicles. This can be accompanied by scrotal swelling, pain, discomfort, or a dull ache in the lower abdomen.
Testicular tumors are usually malignant, with the highest incidence occurring between ages 15 and 35. While most don't resemble the original tissue cells, about 10% do and may secrete hormones. The initial sign across all groups is typically a painless enlargement of the testis. Symptoms should be checked by a doctor because they are not specific to cancer.
2 Britannica SourcesCreated from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles. -
How can doctors detect or diagnose testicular cancer?
Doctors use several methods to detect and diagnose testicular cancer. Initially, a suspicious lump may be investigated through blood tests that check for elevated levels of substances like alpha-fetoprotein and human chorionic gonadotropin. Imaging studies, such as ultrasound, help determine the size and location of a tumor and differentiate it from benign conditions. However, a definitive diagnosis requires the removal of the testicle and microscopic examination of the tissue. Regular self-exams and physicals can aid in early detection.
4 Britannica SourcesCreated from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles. -
What are the main treatments for testicular cancer?
The primary treatments for testicular cancer include surgery, chemotherapy, and radiation, often used in combination depending on the cancer's type and spread.
Initial treatment typically involves surgical removal of the affected testicle, called orchiectomy, which usually doesn't impact fertility. If the cancer has spread, radiation or chemotherapy may be added. Seminomas often respond well to radiation, even after spreading, while nonseminomas typically require chemotherapy.
The prognosis varies with the type of testicular cancer and how far it has spread. When detected early, seminomas have a cure rate exceeding 95 percent. Nonseminomas can spread more rapidly but can still be cured in over 90 percent of cases, largely due to improved chemotherapy treatments introduced in the mid-1970s.
1 Britannica SourceCreated from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles. -
What is the outlook or survival rate for people with testicular cancer?
The prognosis for testicular cancer is generally very good, especially when detected early. The cure rate for seminomas, one type of testicular cancer, is greater than 95 percent when detected early. Nonseminomas, which tend to spread more quickly, can be cured in more than 90 percent of cases.
Treatment for testicular cancer typically involves surgical removal of the affected testis. Additional treatments like chemotherapy and radiation therapy may be used, depending on the type and spread of the cancer.
1 Britannica SourceCreated from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles.
testicular cancer, disease characterized by uncontrolled growth of cells within the testis, the reproductive organ that produces sperm. Testicular cancer represents only 1 percent of all cancers in males, but it is the most common malignancy for men between ages 15 and 35. In the United States, more than 8,500 new cases are diagnosed each year.
Types of testicular cancer
About 90 to 95 percent of testicular cancers are germ cell tumours (germ cells are precursors of sperm in men), which are broadly classified as seminomas or nonseminomas on the basis of their appearance and other characteristics. About 40 to 60 percent of testicular germ cell tumours are seminomas. These cancers tend to be slow-growing and respond well to treatment. Seminomas are derived from immature germ cells in the tissues of the seminiferous tubules. Men who have undescended testes (cryptorchidism) are at an increased risk of developing a seminoma.
Other types of testicular cancers, often referred to as nonseminomas, are derived from mature germ cells and tend to be malignant and to metastasize (spread). Nonseminomas include embryonal-cell carcinomas, teratomas (tumours derived from multiple cell types from multiple layers of germ tissue), and choriocarcinomas. Many of these tumours secrete alpha-fetoprotein or human chorionic gonadotropin (HCG; a hormone with properties similar to luteinizing hormone). HCG, if secreted in sufficient quantities, stimulates the Leydig cells (interstitial cells of the testes) to produce increased quantities of testosterone and estradiol (the main form of estrogen). Excess testosterone has little effect in adult men, but estradiol may cause breast enlargement.
Tumours of the Leydig cells are very rare and almost always benign. They secrete large quantities of testosterone, thereby causing pseudopuberty in prepubertal boys. In adult men the only consistent clinical abnormality associated with a tumour of the Leydig cells is breast enlargement.
Causes and symptoms
Most cases of testicular cancer arise in individuals who have no known risk factors for the disease. An important known risk factor is a developmental abnormality that consists of a failure of one or both testes to descend into the scrotum, which normally takes place around the time of birth. The abnormality, called cryptorchidism, occurs in up to 1 percent of one-year-old boys, and it is associated with a 5- to 10-fold increased risk of testicular cancer, even if the condition is corrected with surgery.
Testicular cancer is typically noticed by the patient as a painless lump in either testis. This lump can be associated with swelling of the scrotum, pain and discomfort in the scrotum, or a dull ache in the lower abdomen. Because these symptoms are not specific to cancer, they should be investigated by a physician.
Diagnosis and prognosis
The initial investigation of a suspicious lump may involve blood tests and imaging studies. Different types of testicular cancer are associated with an increase in specific substances in the blood, including alpha fetoprotein, human chorionic gonadotropin, and lactate dehydrogenase. Ultrasound may be used to determine the size and location of a tumour in a testis and may help distinguish cancer from a benign condition. Ultimately, diagnosis of cancer requires removal of the testis and examination of the tissue under a microscope.
The prognosis depends on the type of testicular cancer found and the extent to which it has spread. Both seminomas and nonseminomas tend to metastasize first to the local lymph nodes of the pelvis and subsequently to distant sites such as the lungs. Seminomas have a cure rate greater than 95 percent when detected early. Nonseminomas tend to spread more quickly and behave more aggressively than seminomas, but they can be cured in more than 90 percent of cases. A dramatic increase in the cure rate, particularly for patients with nonseminomas, has been achieved largely through improved chemotherapy introduced in the mid-1970s.
Treatment
As with many cancers, treatment involves a combination of surgery, chemotherapy, and radiation therapy, depending on the type and spread of the cancer. Virtually all testicular cancer is diagnosed and treated initially by surgically removing the affected testis (orchiectomy). Fortunately, the removal of one testis usually does not affect fertility. If the cancer has spread into the pelvic region or beyond, radiation or chemotherapy may be added to the treatment. Seminomas tend to respond very well to radiation therapy alone, even after the cancer has spread into the pelvis. Nonseminomas often require the addition of chemotherapy.
Prevention
Undescended testes are usually surgically moved into the scrotum before puberty to help prevent the development of cancer. Regular self-examination and physical examination by a physician for testicular cancer can lead to early detection, which provides the best opportunity for a cure.

" height="20" alt="HEW Logo">